Although more in vivo studies are needed to elucidate therapeutic effects and the exact mechanism, our data identified targeting the enzymes in DNA repair pathways for therapeutic treatment may, have the potential to synergize with β-lap for treating human NQO1+ cancer. Here, NQO1 is linked to cancer.